| MYB |
MYB: Myb proto-oncogene protein |
MYBL2 |
MYBL2, BMYB: Myb-related protein B |
0.265 |
Evidence |
|
| PRKCI |
PRKCI, DXS1179E: Protein kinase C iota type |
MAPK6 |
MAPK6, ERK3, PRKM6: Mitogen-activated protein kinase 6 |
0.265 |
Evidence |
|
| COL4A1 |
IPI00021034 |
IL6 |
IL6, IFNB2: Interleukin-6 precursor |
0.265 |
Evidence |
|
| CTTN |
CTTN, EMS1: Src substrate cortactin |
RDX |
RDX: Radixin |
0.265 |
Evidence |
|
| IGFBP3 |
IGFBP3, IBP3: Insulin-like growth factor-binding protein 3 precursor |
IGFBP4 |
IGFBP4, IBP4: Insulin-like growth factor-binding protein 4 precursor |
0.265 |
Evidence |
|
| HDAC3 |
HDAC3: Histone deacetylase 3 |
MTF1 |
MTF1: Metal regulatory transcription factor 1 |
0.265 |
Evidence |
|
| EPHB1 |
EPHT2, EPHB1, NET: Ephrin type-B receptor 1 precursor |
HAVCR1 |
HAVCR1, TIM1, TIMD1: Hepatitis A virus cellular receptor 1 precursor |
0.265 |
Evidence |
|
| THBD |
THBD, THRM: Thrombomodulin precursor |
TEK |
TEK, TIE2: Angiopoietin-1 receptor precursor |
0.265 |
Evidence |
|
| PRKD2 |
PRKD2, PKD2, HSPC187: Serine/threonine-protein kinase D2 |
BLNK |
BLNK, BASH, SLP65: B-cell linker protein |
0.265 |
Evidence |
|
| BRD2 |
BRD2, KIAA9001, RING3: Bromodomain-containing protein 2 |
TERF1 |
TERF1, PIN2, TRBF1, TRF, TRF1: Telomeric repeat-binding factor 1 |
0.265 |
Evidence |
|
| CD79A |
CD79A, IGA, MB1: B-cell antigen receptor complex-associated protein alpha-chain |
SLAMF1 |
SLAMF1, SLAM: Signaling lymphocytic activation molecule precursor |
0.265 |
Evidence |
|
| MATR3 |
MATR3, KIAA0723: Matrin-3 |
ZNF267 |
ZNF267: Zinc finger protein 267 |
0.265 |
Evidence |
|
| C9 |
C9: Complement component C9 precursor [Contains: Complement component C9a; Compl |
SERPINA10 |
SERPINA10, ZPI, UNQ707/PRO1358: Protein Z-dependent protease inhibitor precursor |
0.265 |
Evidence |
|
| NCF4 |
NCF4, SH3PXD4: Neutrophil cytosol factor 4 |
STK38 |
STK38, NDR1: Serine/threonine-protein kinase 38 |
0.265 |
Evidence |
|
| PLCG1 |
PLCG1, PLC1: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 |
RPS6KB1 |
IPI00216132 |
0.265 |
Evidence |
|
| PSTPIP1 |
PSTPIP1, CD2BP1: Proline-serine-threonine phosphatase-interacting protein 1 |
MAP3K8 |
MAP3K8, COT, ESTF: Mitogen-activated protein kinase kinase kinase 8 |
0.265 |
Evidence |
|
| RHOB |
RHOB, ARH6, ARHB: Rho-related GTP-binding protein RhoB precursor |
IRS2 |
IRS2: Insulin receptor substrate 2 |
0.265 |
Evidence |
|
| THBS1 |
THBS1, TSP, TSP1: Thrombospondin-1 precursor |
IGFBP4 |
IGFBP4, IBP4: Insulin-like growth factor-binding protein 4 precursor |
0.265 |
Evidence |
|
| PSCD4 |
PSCD4, CYT4: Cytohesin-4 |
TLK1 |
TLK1, KIAA0137: Serine/threonine-protein kinase tousled-like 1 |
0.265 |
Evidence |
|
| MAPK1 |
MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 |
ROCK1 |
ROCK1: Rho-associated protein kinase 1 |
0.265 |
Evidence |
|
| PAK4 |
PAK4, KIAA1142: Serine/threonine-protein kinase PAK 4 |
SQSTM1 |
SQSTM1: Uncharacterized protein SQSTM1 |
0.265 |
Evidence |
|
| LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
NRBP1 |
NRBP1, BCON3, NRBP: Nuclear receptor-binding protein |
0.265 |
Evidence |
|
| NCF1 |
Neutrophil cytosolic factor 1 variant (Fragment) |
MAP3K11 |
MAP3K11, MLK3, PTK1, SPRK: Mitogen-activated protein kinase kinase kinase 11 |
0.265 |
Evidence |
|
| CDC34 |
CDC34, UBE2R1: Ubiquitin-conjugating enzyme E2 R1 |
HUWE1 |
HUWE1, KIAA0312, HSPC272, KIAA1578, UREB1: E3 ubiquitin-protein ligase HUWE1 |
0.265 |
Evidence |
|
| HLA-A |
HLA-A, HLAA: HLA class I histocompatibility antigen, A-3 alpha chain precursor |
PTPN1 |
PTP1B, PTPN1: Tyrosine-protein phosphatase non-receptor type 1 |
0.265 |
Evidence |
|
- 
- 
-